Financials

Caixabank’s stock gains may be more buy‑back hype than growth, and its potential Cetelem deal faces regulatory and integration risks—data‑driven insights revealed.

Goldman Sachs and SEB slash Gjensidige Forsikring’s target prices but keep a “buy” stance, citing solid fundamentals, diversified products, and strong capital amid low‑rate and climate‑risk pressures.

Citigroup launches structured senior notes, offering up to 90% of equity‑index upside with built‑in barrier protection, ideal for investors seeking capital‑efficient, credit‑spread‑friendly returns.

ATX slips 1.5% as BAWAG’s 7.6% US stake disclosure boosts transparency—see how this shapes Austrian banking outlook.

Explore why Berenberg sees Talanx AG as a strong DAX‑inclusion candidate—dividend‑sustainable, undervalued, and poised for higher liquidity.

Explore how M&G PLC’s 2026 filing reveals hidden voting‑rights gaps and timed Vesuvius share sales, spotlighting governance and market‑impact risks for investors.

Finansinspektionen tightens SEB’s 2026 capital requirement to 2 % overall and 1.4 % core primary capital, strengthening resilience while keeping liquidity and leverage unchanged.

Explore how NAB’s higher loan‑loss provisioning, RBA rate hikes, and narrowing bond spreads could impact earnings, capital, and credit access.

U.S. stocks open higher, led by tech and consumer‑discretionary, while Sun Life Financial stays flat—its stable valuation and regulatory backdrop hint at long‑term value.

Manulife’s 80% quota‑share reinsurance with Munich Re Life US cuts long‑term care risk, releases $3.2 bn in capital, and boosts future growth potential.